Literature DB >> 15676219

Genetic regulation of hematopoietic stem cell exhaustion during development and growth.

Rong Yuan1, C M Astle, Jichun Chen, David E Harrison.   

Abstract

OBJECTIVE: During aging, hematopoietic stem cell (HSC) exhaustion is more severe in BALB/cByJ (BALB) mice than in C57BL/6J (B6) mice. Our objective is to determine whether HSC exhaustion during development from fetus to adult also is more severe for BALB than for B6 mice.
MATERIALS AND METHODS: Hematopoietic stem cells from fetal liver cells (FLCs) and from young adult bone marrow cells (BMCs) were compared using the competitive repopulation assay to measure long-term repopulating ability (LTRA) and HSC expansion after serial transplantation. LTRAs were measured in repopulating units (RU), as the ability to produce donor-type erythrocytes and lymphocytes in lethally irradiated recipients relative to the congenic fresh marrow competitor. To test expansion, FLCs or BMCs were serially transplanted into lethally irradiated carriers whose marrow cells were compared using fluorescence-activated cell staining (FACS), and subsequently tested for LTRA.
RESULTS: BALB and B6 FLCs, respectively, repopulated 2.6 and 13.5 times as well as BMCs. LTRAs correlated with HSC expansion for BALB, but not B6. Per million donor cells, CD34(-) HSC-enriched fractions (HEFs) and total RU values were 6.8 and 4.6 times higher for FLCs than for BMCs in BALB carriers, while these ratios were only 1.2 and 0.97 higher in B6 carriers.
CONCLUSION: In B6 HSC development, LTRA is dissociated from expansion. Although 1 x 10(6) BMCs have much lower LTRA, they expand HSCs as well as 1 x 10(6) FLCs. HSC expansion is partly exhausted in BALB, but not B6, during development.

Entities:  

Mesh:

Year:  2005        PMID: 15676219     DOI: 10.1016/j.exphem.2004.10.014

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  19 in total

Review 1.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function.

Authors:  Yashoda Sharma; Clinton M Astle; David E Harrison
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

3.  Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization.

Authors:  Marnie A Ryan; Kalpana J Nattamai; Ellen Xing; David Schleimer; Deidre Daria; Amitava Sengupta; Anja Köhler; Wei Liu; Matthias Gunzer; Michael Jansen; Nancy Ratner; Timothy D Le Cras; Amanda Waterstrat; Gary Van Zant; Jose A Cancelas; Yi Zheng; Hartmut Geiger
Journal:  Nat Med       Date:  2010-09-26       Impact factor: 53.440

Review 4.  Aging stem cells, latexin, and longevity.

Authors:  Ying Liang; Gary Van Zant
Journal:  Exp Cell Res       Date:  2008-02-19       Impact factor: 3.905

5.  The critical role of agrin in the hematopoietic stem cell niche.

Authors:  Cristina Mazzon; Achille Anselmo; Javier Cibella; Cristiana Soldani; Annarita Destro; Natalie Kim; Massimo Roncalli; Steven J Burden; Michael L Dustin; Adelaida Sarukhan; Antonella Viola
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

6.  Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow.

Authors:  Min Hee Park; Hee Kyung Jin; Woo-Kie Min; Won Woo Lee; Jeong Eun Lee; Haruhiko Akiyama; Herbert Herzog; Grigori N Enikolopov; Edward H Schuchman; Jae-sung Bae
Journal:  EMBO J       Date:  2015-04-27       Impact factor: 11.598

7.  Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice.

Authors:  Jichun Chen; Felicia M Ellison; Keyvan Keyvanfar; Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Neal S Young
Journal:  Exp Hematol       Date:  2008-06-17       Impact factor: 3.084

Review 8.  The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations.

Authors:  Kameshwar P Singh; Fanny L Casado; Lisa A Opanashuk; Thomas A Gasiewicz
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

9.  Factors that may impact on immunosenescence: an appraisal.

Authors:  Joseph Ongrádi; Valéria Kövesdi
Journal:  Immun Ageing       Date:  2010-06-14       Impact factor: 6.400

10.  Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential.

Authors:  Haiming Xu; Satyam Eleswarapu; Hartmut Geiger; Kathleen Szczur; Deidre Daria; Yi Zheng; Jeffrey Settleman; Edward F Srour; David A Williams; Marie-Dominique Filippi
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.